Overview

A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus

Status:
Completed
Trial end date:
2018-08-20
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of nasal glucagon compared to intramuscular (IM) glucagon for treatment of insulin-induced hypoglycemia in Japanese participants with diabetes mellitus.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Glucagon
Glucagon-Like Peptide 1
Pharmaceutical Solutions